Daisley Hubert, Acco Oneka, Daisley Martina, George Dennecia, Paul Lilly, James Errol, Rampersad Arlene, Narinesingh Farhaana, Humphrey Ornella, Daisley Johann, Nathan Melissa
General Hospital, San Fernando, Trinidad and Tobago.
The University of the West Indies, Mona, Jamaica.
Autops Case Rep. 2024 May 22;14:e2024491. doi: 10.4322/acr.2024.491. eCollection 2024.
The vasa vasorum of the large pulmonary vessels is involved in the pathology of COVID-19. This specialized microvasculature plays a major role in the biology and pathology of the pulmonary vessel walls. We have evidence that thrombosis of the vasa vasorum of the large and medium-sized pulmonary vessels during severe COVID-19 causes ischemia and subsequent death of the pulmonary vasculature endothelium. Subsequent release of thrombi from the vasa interna into the pulmonary circulation and pulmonary embolism generated at the ischemic pulmonary vascular endothelium site, are the central pathophysiological mechanisms in COVID-19 responsible for pulmonary thromboembolism. The thrombosis of the vasa vasorum of the large and medium-sized pulmonary vessels is an internal event leading to pulmonary thromboembolism in COVID-19.
大型肺血管的滋养血管参与了COVID-19的病理过程。这种特殊的微血管系统在肺血管壁的生物学和病理学中起主要作用。我们有证据表明,重症COVID-19期间大中型肺血管滋养血管的血栓形成会导致肺血管内皮缺血及随后的死亡。随后,内滋养血管的血栓释放到肺循环中,并在缺血性肺血管内皮部位产生肺栓塞,这是COVID-19中导致肺血栓栓塞的核心病理生理机制。大中型肺血管滋养血管的血栓形成是导致COVID-19患者发生肺血栓栓塞的内在事件。